Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

Factors Predicting Reduced Antidepressant Response: Experience with the SNRI Duloxetine in Patients with Major Depression

(2011) Robert H. Howland et al.   Annals of Clinical Psychiatry

Remission Prognosis for Cognitive Therapy for Recurrent Depression Using the Pupil: Utility and Neural Correlates

(2011) Greg J. Siegle et al.   BIOLOGICAL PSYCHIATRY

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline

(2011) Rudolf Uher et al.   JOURNAL OF AFFECTIVE DISORDERS

Dimensions of Depression and Anxiety and the Hypothalamo-Pituitary-Adrenal Axis

(2010) Klaas J. Wardenaar et al.   BIOLOGICAL PSYCHIATRY

Basal cortisol levels in relation to dimensions and DSM-IV categories of depression and anxiety

(2010) Gerthe Veen et al.   PSYCHIATRY RESEARCH

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

(2009) Rudolf Uher et al.   BRITISH JOURNAL OF PSYCHIATRY

Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials

(2009) J. Craig Nelson   DEPRESSION AND ANXIETY

A dimensional versus a categorical approach to diagnosis: Anxiety and depression in the HUNT 2 study

(2009) Ingvar Bjelland et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Do atypical features affect outcome in depressed outpatients treated with citalopram?

(2009) Jonathan W. Stewart et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Body weight as a predictor of antidepressant efficacy in the GENDEP project

(2009) Rudolf Uher et al.   JOURNAL OF AFFECTIVE DISORDERS

Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features

(2009) Patrick J. McGrath et al.   JOURNAL OF CLINICAL PSYCHIATRY

Atypical Depression: Useful Concept, but it's Time to Revise the DSM-IV Criteria

(2009) Michael E Thase   NEUROPSYCHOPHARMACOLOGY

When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study

(2009) Roy H Perlis et al.   NEUROPSYCHOPHARMACOLOGY

Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants

(2009) Annette Beatrix Brühl et al.   NEUROPSYCHOPHARMACOLOGY

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder

(2009) Andrew F. Leuchter et al.   PSYCHIATRY RESEARCH

Trajectories of change in depression severity during treatment with antidepressants

(2009) R. Uher et al.   PSYCHOLOGICAL MEDICINE

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report

(2008) Maurizio Fava et al.   AMERICAN JOURNAL OF PSYCHIATRY

Activation of Central Nervous System Inflammatory Pathways by Interferon-Alpha: Relationship to Monoamines and Depression

(2008) Charles L. Raison et al.   BIOLOGICAL PSYCHIATRY

Measuring melancholia: the utility of a prototypic symptom approach

(2008) G. Parker et al.   PSYCHOLOGICAL MEDICINE

A comparison of the predictive abilities of dimensional and categorical models of unipolar depression in the National Comorbidity Survey

(2008) J. J. Prisciandaro et al.   PSYCHOLOGICAL MEDICINE